Noxxon Pharma, based in Berlin, Germany, has appointed Don Munoz to the newly created position of chief financial officer. Munoz will strengthen the executive management board and will be based in Noxxon’s new subsidiary office in Boston, Mass.
Before joining Noxxon Pharma, Munoz was head of investment banking at Summer Street Research Partners, an investment banking and institutional securities firm focused exclusively on healthcare. Previously, Munoz led the medical technology investment banking practices at Cowen & Company and Leerink Swann.
He also spent approximately 10 years in the healthcare investment banking group at Alex. Brown & Sons and its successor, Deutsche Bank Securities. In total, he has over 21 years of investment banking experience, with more than 19 of those focused exclusively on healthcare. Munoz has completed more than 100 public and private financings and M&A transactions in his career.